Evidence map›Paper›PMID 35162061›Full record

ArticleInternational journal of environmental research and public health2022

Olfactory Dysfunction in COVID-19 Patients Who Do Not Report Olfactory Symptoms: A Pilot Study with Some Suggestions for Dentists.

Riccardo Favero, Silva Hajrulla, Anna Bordin, Carla Mucignat-Caretta, Piergiorgio Gaudioso, Bruno Scarpa, Lorenzo Favero, Giancarlo Ottaviano

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Subjective versus Psychophysical Measures of Chemosensory Alterations following COVID-19.ORL; journal for oto-rhino-laryngology and its related specialties · 2024
    Article
  4. Observational
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Riccardo FaveroDentistry Section, Department of Neurosciences, University of Padua, 35128 Padua, Italy.
Silva HajrullaDentistry Section, Department of Neurosciences, University of Padua, 35128 Padua, Italy.
Anna BordinSection of Otolaryngology, Department of Neurosciences, University of Padua, 35128 Padua, Italy.
Carla Mucignat-CarettaDepartment of Molecular Medicine, University of Padua, 35128 Padua, Italy.ORCID 0000-0001-5307-0414
Piergiorgio GaudiosoSection of Otolaryngology, Department of Neurosciences, University of Padua, 35128 Padua, Italy.
Bruno ScarpaDepartment of Statistical Sciences, University of Padua, 35121 Padua, Italy.ORCID 0000-0002-9628-5164
Lorenzo FaveroDentistry Section, Department of Neurosciences, University of Padua, 35128 Padua, Italy.
Giancarlo OttavianoSection of Otolaryngology, Department of Neurosciences, University of Padua, 35128 Padua, Italy.ORCID 0000-0003-2433-4761

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSmell and taste dysfunction are frequently reported by SARS-CoV-2 positive patients. The degree of olfactory and gustatory dysfunction varies from a very mild reduction to their complete loss. Several studies have been performed to determine their prevalence in COVID-19 patients, mostly using subjective measurement methods. The literature lacks long-term studies regarding duration and recovery.

methodsWe assessed olfactory performance, using the Sniffin' Sticks olfactory test, in a group of patients who had not reported olfactory dysfunction, around 131 days after their COVID-19 diagnosis.

results11 out of 20 subjects showed no olfactory reduction (65%), while 9 subjects showed reduced TDI score (45%). A total of 13 subjects (65%) scored above the cutoff point for Threshold, 16 subjects (80%) scored above the cutoff point for discrimination and 13 subjects (65%) scored above the cutoff point for identification.

conclusionObjective measurement methods of olfactory performance show a higher prevalence of olfactory reduction compared to patients' self-reported questionnaires. Olfactory dysfunction can last even months after its onset and because of its high prevalence, it could be a screening symptom for suspect COVID-19 cases.

Indexed as

COVID-19Olfaction DisordersCOVID-19 TestingDentistsHumansPilot ProjectsSARS-CoV-2SmellCOVID-19dentistryolfactory disfunctionsmell

Identifiers

PMID35162061
PMCPMC8834295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.